In recent decades, research scientists, molecular biologists, and pharmacologists have
placed a strong emphasis on cutting-edge nanostructured materials technologies to …

Central nervous system disorders, especially neurodegenerative diseases, are a public
health priority and demand a strong scientific response. Various therapy procedures have …

Central nervous system (CNS) disorders especially neurodegenerative disorders are the
major challenge for public health and demand the great attention of researchers to protect …

Neurons and their connecting axons gradually degenerate in neurodegenerative diseases
(NDs), leading to dysfunctionality of the neuronal cells and eventually their death. Drug …

Conventional drug delivery systems are inadequate in providing essential cyto-architecture
restoration and connection patterns because of restrictions posed by the restrictive blood …

Drug delivery to central nervous system (CNS) diseases is very challenging since the
presence of the innate blood–brain barrier (BBB) and the blood-cerebrospinal fluid barrier …

The major neurological disorders found in a central nervous system (CNS), such as brain
tumors, Alzheimer's diseases, Parkinson's diseases, and Huntington's disease, have led to …

Interest in nanoneuromedicine has grown rapidly due to the immediate need for improved
biomarkers and therapies for psychiatric, developmental, traumatic, inflammatory, infectious …

Nanomaterials (NMs) are receiving remarkable attention due to their unique properties and
structure. They vary from atoms and molecules along with those of bulk materials. They can …

Neurological disorders are the most devastating and challenging diseases associated with
the central nervous system (CNS). The blood-brain barrier (BBB) maintains homeostasis of …